regeneron glp-1 boosts obesity pipeline with Hansoh's GLP-1/GIP for $2B BioCentury - Regeneron leans into
Description
For someone looking to drop 15 vanity pounds, the cost may not be justified
Dulaglutide is a long-acting GLP-1 receptor agonist that can be administered weekly, at any time of the day, because of its long half-life of about five days
Nauck MA, Heimesaat MM, Behle K, et al
(2021) 185:R7591
